<SEC-DOCUMENT>0001564590-21-043233.txt : 20210811
<SEC-HEADER>0001564590-21-043233.hdr.sgml : 20210811
<ACCEPTANCE-DATETIME>20210811083053
ACCESSION NUMBER:		0001564590-21-043233
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20210811
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210811
DATE AS OF CHANGE:		20210811

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FIBROGEN INC
		CENTRAL INDEX KEY:			0000921299
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36740
		FILM NUMBER:		211162081

	BUSINESS ADDRESS:	
		STREET 1:		409 ILLINOIS STREET
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94158
		BUSINESS PHONE:		415-978-1200

	MAIL ADDRESS:	
		STREET 1:		409 ILLINOIS STREET
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94158
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>fgen-8k_20210811.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml  version="1.0" encoding="utf-8"?>
<!-- DFIN ActiveDisclosure(SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-08-11T05:37:17.2839447+00:00 -->
<!-- Version            : 5.0.1.648 -->
<!-- Package ID         : b3b6859626854044907f9bbd1850d6f6 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:fgen="http://www.fibrogen.com/20210811" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html" />
<title>
fgen-8k_20210811.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body><div style="display:none">
	<ix:header>
		<ix:hidden>
			<ix:nonNumeric id="F_000001" name="dei:AmendmentFlag" contextRef="C_0000921299_20210811_20210811">false</ix:nonNumeric>
			<ix:nonNumeric id="F_000004" name="dei:EntityCentralIndexKey" contextRef="C_0000921299_20210811_20210811">0000921299</ix:nonNumeric>
		</ix:hidden>
		<ix:references>
			<link:schemaRef xlink:type="simple" xlink:href="fgen-20210811.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef>
		</ix:references>
		<ix:resources>
			<xbrli:context id="C_0000921299_20210811_20210811">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000921299</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-08-11</xbrli:startDate>
					<xbrli:endDate>2021-08-11</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
		</ix:resources>
	</ix:header>
</div>

<p style="text-align:center;border-bottom:Double 2.25pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:2pt;">&#160;</p>
<p style="text-align:center;margin-top:4pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Washington, D.C. 20549</p>
<p style="margin-bottom:2pt;border-bottom:Solid 0.75pt;padding-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-top:15pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FORM <ix:nonNumeric id="F_000000" name="dei:DocumentType" contextRef="C_0000921299_20210811_20210811">8-K</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:2pt;border-bottom:Solid 0.75pt;padding-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-top:13pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CURRENT REPORT</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934</p>
<p style="text-align:center;margin-top:13pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Date of Report (Date of earliest event reported): <ix:nonNumeric id="F_000002" name="dei:DocumentPeriodEndDate" contextRef="C_0000921299_20210811_20210811" format="ixt:datemonthdayyearen">August 11, 2021</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:2pt;border-bottom:Solid 0.75pt;padding-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:24pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000003" name="dei:EntityRegistrantName" contextRef="C_0000921299_20210811_20210811">FibroGen, Inc.</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Exact name of registrant as specified in its charter)</p>
<p style="text-align:center;margin-bottom:2pt;border-bottom:Solid 0.75pt;padding-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="width:31.67%;"></td>
<td style="width:0.83%;"></td>
<td style="width:34.51%;"></td>
<td style="width:0.99%;"></td>
<td style="width:32%;"></td>
</tr>
<tr style="height:12.4pt;">
<td valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000007" name="dei:EntityIncorporationStateCountryCode" contextRef="C_0000921299_20210811_20210811" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></p></td>
<td valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000006" name="dei:EntityFileNumber" contextRef="C_0000921299_20210811_20210811">001-36740</ix:nonNumeric></p></td>
<td valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000008" name="dei:EntityTaxIdentificationNumber" contextRef="C_0000921299_20210811_20210811">77-0357827</ix:nonNumeric></p></td>
</tr>
<tr style="height:20.9pt;">
<td valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(State or other jurisdiction</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of incorporation)</p></td>
<td valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Commission</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">File Number)</p></td>
<td valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(IRS Employer</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Identification No.)</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FibroGen, Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000009" name="dei:EntityAddressAddressLine1" contextRef="C_0000921299_20210811_20210811">409 Illinois Street</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000010" name="dei:EntityAddressCityOrTown" contextRef="C_0000921299_20210811_20210811">San Francisco</ix:nonNumeric>, <ix:nonNumeric id="F_000011" name="dei:EntityAddressStateOrProvince" contextRef="C_0000921299_20210811_20210811">CA</ix:nonNumeric> <ix:nonNumeric id="F_000012" name="dei:EntityAddressPostalZipCode" contextRef="C_0000921299_20210811_20210811">94158</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Address of principal executive offices, including zip code)</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonNumeric id="F_000013" name="dei:CityAreaCode" contextRef="C_0000921299_20210811_20210811">415</ix:nonNumeric>) <ix:nonNumeric id="F_000014" name="dei:LocalPhoneNumber" contextRef="C_0000921299_20210811_20210811">978-1200</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Registrant&#8217;s telephone number, including area code)</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Not Applicable</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Former name or former address, if changed since last report.)</p>
<p style="text-align:center;margin-bottom:2pt;border-bottom:Solid 0.75pt;padding-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-top:13pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:3pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr style="height:12.4pt;">
<td valign="top" style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000015" name="dei:WrittenCommunications" contextRef="C_0000921299_20210811_20210811" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="bottom" style="width:96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td>
</tr>
<tr style="height:12.4pt;">
<td valign="top" style="width:4%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000016" name="dei:SolicitingMaterial" contextRef="C_0000921299_20210811_20210811" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="bottom" style="width:96%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td>
</tr>
<tr style="height:12.4pt;">
<td valign="top" style="width:4%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000017" name="dei:PreCommencementTenderOffer" contextRef="C_0000921299_20210811_20210811" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="bottom" style="width:96%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule&#160;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td>
</tr>
<tr style="height:12.4pt;">
<td valign="top" style="width:4%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000018" name="dei:PreCommencementIssuerTenderOffer" contextRef="C_0000921299_20210811_20210811" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="bottom" style="width:96%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule&#160;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section 12(b) of the Act:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-weight:bold;;font-size:8pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:35%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Title of each class</p></td>
<td valign="bottom" style="width:30%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Trading Symbol</p></td>
<td valign="bottom" style="width:35%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name of each exchange on which registered</p></td>
</tr>
<tr>
<td valign="top" style="width:35%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000019" name="dei:Security12bTitle" contextRef="C_0000921299_20210811_20210811">Common Stock, $0.01 par value</ix:nonNumeric></p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000020" name="dei:TradingSymbol" contextRef="C_0000921299_20210811_20210811">FGEN</ix:nonNumeric></p></td>
<td valign="top" style="width:35%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000021" name="dei:SecurityExchangeName" contextRef="C_0000921299_20210811_20210811" format="ixt-sec:exchnameen">The Nasdaq Global Select Market</ix:nonNumeric></p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:23.33%;text-indent:-23.33%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Emerging growth company&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000005" name="dei:EntityEmergingGrowthCompany" contextRef="C_0000921299_20210811_20210811" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9744;</span></p>
<p style="margin-bottom:2pt;border-bottom:Double 2.25pt;padding-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr style="height:12.4pt;">
<td valign="top" style="width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="part_1_2_1">Item 8.01</p></td>
<td valign="bottom" style="width:91%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Other Events.</p></td>
</tr>
</table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On August 11, 2021, FibroGen, Inc. (&#8220;FibroGen&#8221;) issued a press release announcing that the U.S. Food and Drug Administration (the &#8220;FDA&#8221;) has issued a complete response letter regarding the New Drug Application (&#8220;NDA&#8221;) for roxadustat for the treatment of anemia of chronic kidney disease. The letter indicates the FDA will not approve the roxadustat NDA in its present form and has requested additional clinical study of roxadustat to be conducted, prior to resubmission.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A copy of such press release is filed as Exhibit&#160;99.1 to this report and is incorporated herein by reference.</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr style="height:12.4pt;">
<td valign="top" style="width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;" id="part_1_2_2">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;9.01</p></td>
<td valign="bottom" style="width:91%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Financial Statements and Exhibits.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:101.11%;">
<tr>
<td style="width:2.18%;"></td>
<td style="width:6.16%;"></td>
<td style="width:1.67%;"></td>
<td style="width:50.46%;"></td>
<td style="width:40.65%;"></td>
</tr>
<tr style="height:7.8pt;">
<td valign="top">
<p style="margin-bottom:6pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)</p></td>
<td colspan="3" valign="top">
<p style="margin-bottom:6pt;margin-top:6pt;margin-left:10.8pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibits</p></td>
<td style="border:none;padding:0;"></td>
</tr>
<tr>
<td colspan="2" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td colspan="2" valign="bottom" style=" border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit&#160;No.</p></td>
<td valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p></td>
<td colspan="2" valign="bottom" style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6pt;;text-indent:-6pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
</tr>
<tr>
<td colspan="2" valign="middle" style=" border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="3" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td colspan="2" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99.1</p></td>
<td valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p></td>
<td colspan="2" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="fgen-ex991_6.htm"><span style="text-decoration:underline;">Press Release titled &#8220;FibroGen Receives Complete Response Letter from the FDA for Roxadustat for Anemia of Chronic Kidney Disease&#8221; dated August 11, 2021</span></a></p></td>
</tr>
<tr>
<td colspan="2" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td colspan="2" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104</p></td>
<td valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td colspan="2" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="part_1_2_3">SIGNATURES</p>
<p style="margin-top:13pt;margin-bottom:0pt;text-indent:5%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="3" valign="bottom" style="width:51%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FIBROGEN, INC.</p></td>
</tr>
<tr>
<td valign="top" style="width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dated: August 11, 2021</p></td>
<td colspan="3" valign="bottom" style="width:51%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:49%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="width:3.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="bottom" style="width:0.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="width:47.6%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Michael Lowenstein</p></td>
</tr>
<tr>
<td valign="top" style="width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="width:3.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="width:0.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="width:47.6%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Michael Lowenstein</p></td>
</tr>
<tr>
<td valign="top" style="width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="width:3.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="width:0.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="width:47.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Legal Officer</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:2pt;">&#160;</p></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>fgen-ex991_6.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
fgen-ex991_6.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 99.1</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:10pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><img src="gkc5xasf2e4c000001.jpg" title="" alt="" style="width:287px;height:79px;"></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:14pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FibroGen Receives Complete Response Letter from the FDA for Roxadustat for Anemia of Chronic Kidney Disease&nbsp;&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:14pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Hlk56078963"></a>SAN FRANCISCO, AUGUST 11, 2021 (GLOBE NEWSWIRE) -- FibroGen, Inc.&#160;(NASDAQ: FGEN) today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the New Drug Application (NDA) for<a name="_Hlk56078963"></a> roxadustat for the treatment of anemia of chronic kidney disease (CKD).</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The letter indicates the FDA will not approve the roxadustat NDA in its present form and has requested additional clinical study of roxadustat be conducted, prior to resubmission.&#160;&#160;</p>
<p style="Background-color:#FFFFFF;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;We are deeply disappointed with this result, and this is an unfortunate day for patients suffering from anemia of CKD in the United States,&#8221; said Enrique Conterno, Chief Executive Officer, FibroGen. &#8220;Roxadustat is changing the lives of patients around the world, and we and our partner AstraZeneca will discuss next steps in the U.S.&#8221;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Roxadustat is approved in China, Japan, Chile, and South Korea for the treatment of anemia of CKD in both non-dialysis-dependent (NDD) and dialysis-dependent (DD) adult patients and has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP), the European Medicines Agency&#8217;s committee responsible for human medicines. The European Commission decision is expected by the end of August. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:12pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">About Anemia of CKD<font style="font-weight:normal;"><br />Chronic kidney disease (CKD) is generally a progressive disease characterized by gradual loss of kidney function that may eventually lead to kidney failure or end stage renal disease, requiring dialysis or kidney transplant. CKD is estimated to occur in approximately 10-12 percent of adults worldwide and is predicted to become the fifth most common cause of premature death globally by 2040.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Anemia, a serious medical condition in which patients have insufficient red blood cells and low levels of hemoglobin, is a common early complication of CKD, affecting approximately 20 percent of CKD patients. Anemia of CKD is associated with an increased risk of hospitalization, cardiovascular complications, and death, and can also cause significant fatigue, cognitive dysfunction, and reduced quality of life. Blood transfusions are used for treating severe anemia; however, they may reduce a patient&#8217;s opportunity for kidney transplant and can increase the risk of infection and/or complications such as heart failure and allergic reactions.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 99.1</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">About Roxadustat</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Roxadustat, an oral medicine, is the first in a new class of medicines, HIF-PH inhibitors that promote erythropoiesis, or red blood cell production, through increased endogenous production of erythropoietin; improved iron absorption and mobilization; and downregulation of hepcidin. Roxadustat is also in clinical development for anemia associated with myelodysplastic syndromes (MDS) and for chemotherapy-induced anemia (CIA).</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Roxadustat is approved in China, Japan, Chile, and South Korea for the treatment of anemia of CKD in adult patients on dialysis (DD) and not on dialysis (NDD). In Europe, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion relating to the use of roxadustat for the treatment of adult patients with symptomatic anemia associated with chronic kidney disease (CKD). Several other licensing applications for roxadustat have been submitted by Astellas and AstraZeneca to regulatory authorities across the globe, and are currently in review.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Astellas and FibroGen are collaborating on the development and commercialization of roxadustat for the potential treatment of anemia of CKD in territories including Japan, Europe, Turkey, Russia, and the Commonwealth of Independent States, the Middle East, and South Africa. FibroGen and AstraZeneca are collaborating on the development and commercialization of roxadustat for the potential treatment of anemia of CKD in the U.S., China, other markets in the Americas, in Australia/New Zealand, and Southeast Asia.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">About FibroGen</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">FibroGen, Inc. is a biopharmaceutical company committed to discovering, developing, and commercializing a pipeline of first-in-class therapeutics. The Company applies its pioneering expertise in hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF) biology to advance innovative medicines for the treatment of unmet needs. The Company is currently developing and commercializing roxadustat, an oral small molecule inhibitor of HIF prolyl hydroxylase activity, for anemia of chronic kidney disease (CKD). Roxadustat is also in clinical development for anemia associated with myelodysplastic syndromes (MDS) and for chemotherapy-induced anemia (CIA). Pamrevlumab, an anti-CTGF human monoclonal antibody, is in clinical development for the treatment of locally advanced unresectable pancreatic cancer (LAPC), Duchenne muscular dystrophy (DMD), and idiopathic pulmonary fibrosis (IPF). For more information, please visit www.fibrogen.com.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Forward-Looking Statements</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This release contains forward-looking statements regarding our strategy, future plans and prospects, including statements regarding the development and commercialization of the company&#8217;s product candidates and product, the potential safety and efficacy profile of our product candidates and product, our clinical programs and regulatory events, and those of our partners, and the commercial and clinical success of <font style="text-transform:uppercase;">HIFRENZO</font> (roxadustat) in anemia of CKD. These forward-looking statements include, but are not limited to, statements about our plans, objectives, representations and contentions and are not historical facts and typically are identified by use of terms such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;on track,&#8221; &#8220;could,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; and similar words, although some forward-looking statements are expressed differently. Our actual results may differ materially from those indicated in these forward-looking statements due to risks and </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 99.1</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">uncertainties related to the continued progress and timing of our various programs, including the enrollment and results from ongoing and potential future clinical trials, and other matters that are described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and our Quarterly Report on Form 10-Q for quarter ended </font><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June 30, 2021</font><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> filed with the Securities and Exchange Commission (SEC), including the risk factors set forth therein. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release, and we undertake no obligation to update any forward-looking statement in this press release, except as required by law.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contacts:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FibroGen, Inc.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Investors:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Michael Tung, M.D.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate Strategy / Investor Relations</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">+1.415.978.1434</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">mtung@fibrogen.com</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Media:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GCI Health</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">FibroGenMedia@gcihealth.com</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:14pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>gkc5xasf2e4c000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gkc5xasf2e4c000001.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #Z X0# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@!!U/U_H**!U/U_H** %HHHH **** "OGC]I7]F3
MX;?M5^"-'^'_ ,49/%$6@:'XQT+QQ9GPGX@N?#FH-K7AUKAK!9[VU2226R)N
M9//M2 LIV-N5D4CZ'HK6C6JX>K"O0J3I5J<N:G4@W&<);7BUL]3AS/+,OSK
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M_P!0,P_Z#\#_ .7/_P H_JWI<_UFPO\ T#8G_P I?_+/ZMZ7_P!,BBO\S?\
MX>N?\%*O^CT_C5_X--)_^5-'_#US_@I5_P!'I_&K_P &FD__ "IH_P!0,P_Z
M#\#_ .7/_P H_JWI<_UFPO\ T#8G_P I?_+/ZMZ7_P!,BBOYA/\ @W9_:T_:
M;_:<U7]JN+]H;XV^-_B_%X//PU_X16/QA=6ERN@_VK;:V^I?8!:VEKL^VM!
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MS1//NKZ!\#YPL-[;FPSK<O-]3527MMK\BER>Q=3IRJH_>T3ZGF+B+ .M[/\
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M%.]M_P!J_P"%>D?$O5M9UO5/$/\ PEKVWA[QK9Z);^&]2BENHK#7]-O=2O(
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M1O#7QJ^#&O\ @2W@:Y\5?!;QYY.@>'_#?B'Q,D5S<-I?B W%I=^*_$YU&/\
ML[3;&SO4^W2F1;6 Q-@_.'Q<^+GP[UG]L[Q'XI^/?[5?Q9O?A]^S7JEU\/?@
MKX@M/#OA#Q#\7]9^.%Q-;_VSX<\._#_3]%N5US0KM[+46LM<ETB:SM[JUL+>
MZN+5IO.CY[X?_ ?_ (*Y?\%#/B)X=^)OB*YU+X8?"CP3K?BS6?@'XR_:=T[3
M7\1^!M0L[R"WT75M?^$&AVMI#K_BXV\1-IJ6LZ3=Z)%(3+;K&T;-7Z Y8C#9
M9@\'F&9X*OAXP>+S&6<T:]?ZPZ\>;"X3"RKT?:J=&E[]1TY?6*4ZLK1<8J%7
M^<.&.!\KXSXVXBX[R3@SB3A#!/&1X<X0QW &=Y!PU'!0R:O'#<0YWBZ."S/Z
MIFD,QS6A/"4E' X[*Z^#RZ+DJN*J-X3V_P <?MD>*/VAM?\ AS<?\%*O@-\8
M/A-^R3HD6C:I<>&]*\+>)-&\'^/_ (GVP,D+?$JUF"ZMK?A5;BW%SX;\/:;?
M( );A]32^C=-OOW[3W_!1[]A+]HSX>Z#^S?\&O@U\6_VB/']]J&D6GPR\%_"
M/PM>_#7Q#\.[V$>38>-/"7C*^M+;3_#$WA-TM;HVR)]DGBB2"^MY+8>6WTIX
M>_X([^ OB#>OXT_;:^-WQ>_:Y^(NJZ7X>75(_%?BB^\/_#C0];T4!S>>#?!.
M@O8:?I]N9N(?M<,T_E*H<J&*#T#XE?\ !(+]EKQO=W.N^%I_'?P@\9W=U;W$
MWC/X9^('T'6%CA@2VEM;=(XS:6UO=V\<<=RL,*;]N_\ UC%CX#Q_"E2I0YUC
ML)/#<TJ/U"5;^S*=9V?.J-5QQLE*6E:I"=*I4A"$8QBK-?M#RGQSX9DUEF:\
M.^(^524(U<)Q/AJ'#G%7U:/)'V5'/,J=?)L77A2A+V7U_**495JU2O7Q<E:B
MOS2T'7?^"OFJ>(O@_P#LW_M3_'GP[^Q=X<NM2TZ+P7\;O#UI:_$#QG\9[)+N
M2)_ 7C7X@PD^!O!WQ(DTDVR::D]I;GQ%JS-';0S7.U6\\_:3_P"":?P)_8%_
M:=_9Y_:X^(%OXU_:C^"_C#XI+X=^/,WQRUR+7I?!/C7Q3.L'@OXPZGK3V]II
MD6B:+X@NK5;VPOK5X@D:PH3 WEI[Q^TI^PC_ ,%-?!?PQO/A5\)/V@)?C]\#
MYQJ&DV?@;7X=$M?'/A_PU;H;VSOKCQ)XAM7O+S7UG>86%_H5^NJ6-TJ2V<D+
M&/'QYX1^->M_&J_\??L0?MO_ !I_:%^$'PR\<>%-)\'?"VW^)>@^%K2SV65G
M:Z9;6_Q"U"\T==3O;>#Q%8K=:;XC@N!9RVEO US>BY$EPGJX;"U*T)8O+<PR
MR>#Y*T,PPF44*]+$SPU1\CK>QC0>/I5TIRJPISJU:=.=.4J=54WRKQJOC1A\
MNS7#9!QCP+Q;PCFE>IAH8/'\5XWA[#\/5L6XPG4P^6\0U<YAD^8TZ;48-Q^J
MXFM&I3IO"?6I.DOZ[O"^E^%--TBUD\&Z;H&G:'J4,&I69\-V.GV.F7L%W!'+
M;7T TV**VG2XMFB>*X4,)(2A5BFVOGG]D7P5'\._AOXD\)FY$]Y#\5OBAKMY
M$6#2VQ\4^,=4UVW20#E=T%VK)GJ,^E?G5_P2F^.'Q>^(_P 'O'WP3U7XI:%X
MI^,_[+WBN_\ A)JLGBFXTS4-"\2>%-%$5MX$\:>&[;PL8-3?PU=^'X["U%].
M9&FO$=7GWL-_J7POU/\ ;HU3X[?M0^&O"OB7]F"&Y\)^)_AXNO)K6@?$E[#S
M]>\%1ZK8MHB:??QS1!K)@=4^VL[2:AOD@*QD@_'O+*U)9K@YXS#05!X;$5)5
M9U8<ZA55&C-WI.2C*.-33MJY1773]&SOB7#8/.N#LS_U?SS'UL;//,FP$\MH
MX/%PE2QN7RS>K.C.&.C3J>VI<.0JPCS)J@JDW:4>27ZRSSPVL$US<RQP6]O%
M)///*XCBAAB0R2RRR,0J1QHK.[L0JJ"20!7XC?L!1I^T/^W3^V=^UCJ^HW6K
MKX-UR'X(?"C7='VKX0U_X=QR7,K313!2NI7MFVD6"^?#)L3SW+98C/T;^TU\
M5OVK_P!G_P#9E^,WQ1^)-U^S_P"(8/#O@G45ATWPG9^--+N;JYU,)I(2'^WK
MZ6.XD07S3I;H#)((F!5E!KYA_P"";U_^T+^SI^R-\-/"WA?]E#Q/\4M+\7QW
MWQ-@\6Z7\2_A[X;@N+?QS(FL6EHVFZW+%J436=L\<8\\'&["\5V8# SP^39M
MB:5?"3K8RIA\JH5/K>'H0]G+_:L:HU,5*BKN$*%*4.9.4:LFK\K/@^+^*L)G
M'B=X=9/F&5\18;+>&L%G''^:8-\/9OFF)6/BED'"SJX+(J.9S488K%YMCJ6(
M<)QP]?+Z49\BQ$6_W/HKY=\(?&_XPZG<1'QY^S#XQ^'FF$;KC4I/&_@[Q9]F
M4 DEK+P]++<R8 X"#))P*V/"G[4/PR\8?$.?X9Z;:^/K+Q!;:=J6J7%]KWP\
M\6:#X6AL])B,UX\GBK5-,MM#1EC!:-#>!I<'R]V#7SDL#BH\[5-552@ZE2>'
MJTL3"$%O*53#SJPBEYR/VK#\69!7^J*6-G@JF/Q,,)@L/F^!S#),7B\34MR4
M</@\XPF!Q=6<[I14*+N]$[GI_P 3OB7X*^#O@#Q9\3OB+KEKX;\%^"M$O_$'
MB'6+LGR[73].MWN)O+C7,EQ<RA/*M;6$--<SO'#$K.X%?/O[&OQJ^+/[1/PZ
MU7XT?$'P)%\-?!?CS79-3^"7A#4;:[MO'%O\-(HA:Z=K7CM)W,$>J>)YX7U[
M3K:U@MQ:Z/>V<<R-*2Y^4O ?C&7_ (*7?%76-2G\-WL7[#/P0\726GAV35[>
M6"T_:<^+'AB_0_VY);3B,W?PL\":E!%-HPB'D:_XBM;Q-1%U8Q1P1_K-##%;
MPQ6]O%'!!!&D,$$*+%###$H2.**- J1QQHJHB(H5% 50  *TKTH8.D\/4IJ6
M-FX3JMN_U6G92C123M[>=U*LW=TH\M+2;JI>U3G*O-582MAXJ48)+^-+9U+_
M //N.JIVMSN\]8\C<E%%%<!TA7\>?_!TQ_R-7[&/_7C\6?\ T'P]7]AE?QY_
M\'3'_(U?L8_]>/Q9_P#0?#U?3<'_ /)08+_#BO\ U$KGD9[_ ,BO$^M'_P!/
MTS^4.BBOT,_X);?LD^ OVW_VPO#G[/?Q+UGQ'H'A/6/ ?COQ1/J7A2:UM]96
M^\+V%M=V4*2WD%S MO*TKB?,+.P"JNW)9?V3$5Z>%P];$UKJEAZ4ZU5Q7-)0
M@N:34>K26B6Y\%1I3KU:=&%N>K.,(W=ES2=E=]%=[GYYT5_<3_Q#+_L9?]%4
M^.O_ (./#W_REH_XAE_V,O\ HJGQU_\ !QX>_P#E+7S7^NN0_P#/W%?^$LO_
M )+^K>E_7_U>S+^2C_X.7E_=]?N\S^':BO[B?^(9?]C+_HJGQU_\''A[_P"4
MM'_$,O\ L9?]%4^.O_@X\/?_ "EH_P!=<A_Y^XK_ ,)9?_)?U;TN?ZO9E_)1
M_P#!R\O[OK]WF?P[45_<3_Q#+_L9?]%4^.O_ (./#W_REH_XAE_V,O\ HJGQ
MU_\ !QX>_P#E+1_KKD/_ #]Q7_A++_Y+^K>ES_5[,OY*/_@Y>7]WU^[S/C__
M (-9O^0S^V?]?A-_Z2>(*_4W_@X+TCQ!K/\ P30^)D/AW3M7U*XL_''PUU+4
M(]&CN9)K?1K'Q$LNI7MV+8AETVUA_>7SR?N5BYE!7BOH?_@G[_P2_P#@K_P3
MJNOBC=_"/Q9X]\3/\5O^$<_MU?&M[IUVEG_PC4=['9_V<+"RL_+\U;Z3S_-\
MS<57;MYS]^>/_ ?A+XH^"?%/PZ\>:+:^(_!GC70]1\-^)M"O?,%KJFC:K;26
ME]9S-"\<R+-!(R^9%)'*AP\;JP!'P.8YQAZG$L<WPRG5P].O@JR4XNG.2P]*
MC&I'E;T=X22UL]'LSZ;"X&K#*7@:KC"K*G7@W%\T4ZLZDHZI:JTE?3OHS_)E
M#!@&4AE8 JR_=*D9!&.,$<C':FRM&D;M*5$2JQD+?=" 98M[8ZU_1M^U[_P;
MF_M/_#SQY>WG[(SZ!\8_A=KNN7K^'_#>M^(=/\)^*_ &BF)9X+#6]2UJ2'3]
M=BAG=['3I--19$LH8&NOWOF5T_[$O_!N=\?O&?C[1_$W[:,N@_#+X9>&O$"R
MZW\-M"UNS\4^)_B)I]M +JUMX-<T>272=(T2]O%%AK<-V/M\EA)*;+]Y@C].
M?$F2+#?6_P"T*#@H<_LE)?66_P#GVL/_ !54O[NL5"^O/R>\?'K*<Q=7V/U6
MHI<W+SM?NEM[WM?@Y;.^_-;3EYO=/Z'_ /@BSX?^('AG_@FU^S?I?Q,L];L?
M% T'6;W[/X@:=M1&BZCXAU.]\/2DW!,HM)]%GLIK 9V?8WA\L!-HK]!_C)_R
M2'XJ_P#9-_'/_J,:I78>'M TCPIH&A^%_#]E%IN@^&]'TS0-$TZ$N8=/TC1[
M*#3M-LHC(SR&*UL[:&",N[N4C&YF;)/'_&3_ ))#\5?^R;^.?_48U2OQ>MB/
MK685,3R*'UC%RK<BVC[2LY\J]+V/T"E2]AA:=&[E[*A&GS/>7)!1O\[7/\G>
MV_U;?]?%W_Z535L:-_R,'AC_ +&SPI_ZD>F5CVW^K;_KXN__ $JFK8T;_D8/
M#'_8V>%/_4CTROZ#/RZ'V?\ MW]#_6:\*_\ (L>'/^P#H_\ Z;[>MZL'PK_R
M+'AS_L Z/_Z;[>MZOYP>[]7^9^KK9>B_(****0PHHHH **** "BBB@ HHHH
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MPOC1IWFVUK%#/"WE_ /P9J:[ ?$GB6#SH/&>I6,OV[P[I5S:FTDAFED,FO\
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MS4[;P6E^3&<08;#RE3H0>)G'1R4E&DGIHIVDY=;N,;=F];?Z(WQ-_P""O_\
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MUM\,_#'_  3!%W\3=;TKX<^!_P!F7Q/KW@+6?%6OW8MM-N4?;XH$EJ#NDGG
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MBCX>>(Q'Y)UWP9K=]X>U9K<NKO:O>Z?+#,]M*4430,Q21<JPP:_IK_X)P_\
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M:I2BU:2UBW\QF665<NJ14I>THSO[.JE:[6\91N^6:WWM):I[I?HC_P $G/\
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M??[/=QY]Z_TWO^"C/_)AW[7'_9!/B/\ ^H[>5_E^:=_R#['_ *\[;_T2E:<
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M:5+H]W\&?AWXOM[G7="U>/0KAY8[KQ/JNGV@%IJK9DT/3WFT^!F:?S$^MO\
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MJ5*4*<)QFM?QY_\ !TQ_R-7[&/\ UX_%G_T'P]7]AE?QY_\ !TQ_R-7[&/\
MUX_%G_T'P]7H\'_\E!@O\.*_]1*Y]5GO_(KQ/K1_]/TS^4.E"R.<10W%P_\
MSSM;>>ZF([D0V\<LI4?Q,$*KU8BDK]J/^#??3=-U?_@IGX(L=6TZPU2RD^$'
MQ>=[/4K.WOK5I(]'LGCD-O=1RQ>9&PRDFS>N6"L S _L.-Q/U/!XK%N#J+"T
M*E=TU+D<U3BY.*E:7*W:U^65NS/A,/1^L5Z-#FY/;584^:U^7GDHWM=7M>]K
MJ_='XM>1>_\ 0*UO_P $>L?_ "#1Y%[_ - K6_\ P1ZQ_P#(-?ZRW_"OO 7_
M $)'A#_PFM&_^0J/^%?> O\ H2/"'_A-:-_\A5\'_P 1!I_]"J?_ (6Q\O\
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M>N?\1,?[5'_1(_AO_P!^[C_Y,K^:TSJ"1Y5WP<<65X1^!$!!^H.#VI/M"_\
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ML'A\OHX=XJIBJ5>M'#X?&15!.:C0Q#NTXN2<9J&!XQ^*?[5?_!:C]I&7P/\
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M:2PN3X3,,DQ/O4Z56GC:V(J3C3<ZE->0?\%B?@O<>/OV)]?\9^$X_&$7B_\
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MFE8<B,2ER.BU\&HR;45%N3=E%)MM]DM[^1])=)7;26]^GWG55_GP_P#!>/\
M:WTO]I[]MF_\*^$KZRU7P%^SKI4WPZT35+>SN+.\G\4W,J3_ !!L[[S_ /CY
M33->M1:6-U"!#/;J'3(P:_6'_@JG_P %[?"%OX.\1? /]A?Q,VN>--;?5?#7
MCGXV06L]OIO@:TMKB?3]6T_P8MW'&^J>(KU4V6>MK$VEP64T]Q93M=+;3C^/
MB6:XN9I[J[N;F]O+J:2YN[V]GEN[R\N9F+S7-W=3L\]S<S.2\L\SO)(Q+,Q-
M?IW!W#^(PDY9IC:<J-25.5/"T)IQJQC.W/7G!J\.:%Z=.+M)QE.323@W\AGV
M9TZT5@\/)3BI*5:I'6#<=8TXO[5G[TFM%)12;:E:.O['O^#7OX:>+-%^&7[3
M7Q6U#3O)\'?$'QAX0T3PMJA(/V^]\&:?JMIXAA3C(%G<7MJKX."SKQD9K^/'
M2-%UCQ)J^E>'/#MC=:GK_B#4K'1=&T^RMY+JYNM2U.YBLK2.."%6DD FF1Y=
MJG9$KN>%-?Z9?_!-G]E.V_8U_8]^%'P6>P&G^)K?36\4_$*%+DW4+_$+Q-';
MWGBJ6WDW,H@-Z@CB1#M58\@9)KT.-L;"AE'U6Z=7'5H04>JI4)QK3G:]U:<:
M4;ZKWFK=5R\/8>57'>WL^3#PDV^G/43A&/;5<SMOIZFC_P %)_\ DP7]KS_L
M@OQ"_P#3%<U_F#Z=_P @^Q_Z\[;_ -$I7^GQ_P %)_\ DP7]KS_L@OQ"_P#3
M%<U_F#Z=_P @^Q_Z\[;_ -$I7)P#_P B_'_]AE/_ -,HWXF_WG"_]>)_^G$?
M2?['_P#R=[^RI_V<+\*__4HLJ_U0:_ROOV/_ /D[W]E3_LX7X5_^I195_J@U
MYOB!_O.6?]@]?_T[$Z^&/X.+_P"OU/\ ]-A1117YZ?4'X"?\''?P^U[QG^P%
M;ZSX=\.3:U/X$^+W@KQ1KNH6MMYTWA_PE;0ZM%K.IW$P4O;Z<DLMBMVY98\M
M%O[5_!B"" 1R",@CN#T-?ZKO[2'P7\/_ +17P'^*WP/\5"Z;0/B9X,U?POJ(
MLI1!=%+R'?#Y,K$*C?:HH,[B%*[E8@$U_EW?&3X0^./@%\5?'WP:^(^C3Z%X
MQ^'GB;5/#FJV,RDQL+.X86EU97&/+OK*XLV@>&]MR]O,=_ENP7-?JW F-A4P
M&(P+:57#5W64>LJ5=17,E?7EJ1<965ES0N[R1\7Q)AY1Q-+$V;A5IJFWTC.F
MWIZRBTUWY9=C[G_X(_\ [2/A_P#9<_;^^#?CSQ;% /#'BYM1^$VN:K?:G!I.
ME^%[+QY]GLSXJU2\N66W2RT>2W1Y@Y!82A5()Y_TD8)X;J"&YMI8[BWN(HY[
M>>%UDAFAF0212Q2(2DD<B,KHZDJZL&4D$&O\CF1$E4HZJRDJV& 8;D970D'(
M.UU5AD8R!7]BO_!);_@NG\/6\#>!?V9_VQM;/A/QEH4FF>#/ 7Q<NQ--X?\
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M-_R+,'_UZ_\ ;Y!1117SYZ85_F$_\%'_ /D_[]L#_LN'B?\ ] LZ_P!/:O\
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MX?-Z\:G#^*4J<Z:E4PN;UZ=+ZU0A6E3K3]E'^GBBO)?A7\8OAA\4/"7A'7/
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M&?[.\2^&[\@36.IZ?.(Y<)(L%[$C6=XDMM*Z5_GN?MY_\$R_VC_V _%.K_\
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M1D@41QQDA?YXOCE_P1A_X*'_  -U;Q/#<_!"]^)/A/PIIRZI??$/X=7EK?\
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M !1110 4444 %%%% #=J_P!U?^^11L7^ZO\ WR/\*=10 =. ,"BBB@ HHHH
M**** "BBB@ HHHH ;L7^ZO\ WR/\*YV7P;X1FOCJ<WA;P]-J+'<U]+HVG273
M-_>,[VYE+?[1;=GG-=)133:V;7HVA-)[I/U5Q@CC4!5C0    *H  X   P !
MP .E.  X  'L,4M%(84444 %%%% !1110 4A /4 _4 _SI:* &&.-AAHT89!
MP44C(Z'D=1VI=B_W5_[Y'^%.HH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@!!U/U_H**!U/U_H** %HHHH **** "BBB@
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M/V=K']H+PSIWB;P%\=[K2?&">#+S2K#P!\8-/N[>+4?B;X8GL&(N?%?AQ/\
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M@*^';IYOF&82C5J4G2Y2BBBO(/T@**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!!U/U_H**!U/U_H** %HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $'4_7
M^@HH'4_7^@HH -P]1^=&X>H_.EHH 3</4?G1N'J/SI:* $W#U'YT;AZC\Z6B
M@!-P]1^=&X>H_.EHH 3</4?G1N'J/SI:* $W#U'YT;AZC\Z6B@!-P]1^=&X>
MH_.EHH 3</4?G1N'J/SI:* $W#U'YT;AZC\Z6B@!-P]1^=&X>H_.EHH 3</4
M?G1N'J/SI:* $W#U'YT;AZC\Z6B@!-P]1^=&X>H_.EHH 3</4?G1N'J/SI:*
M $W#U'YT;AZC\Z6B@!-P]1^=&X>H_.EHH 3</4?G1N'J/SI:* $W#U'YT;AZ
MC\Z6B@!-P]1^=&X>H_.EHH 3</4?G1N'J/SI:* $W#U'YT;AZC\Z6B@!-P]1
M^=&X>H_.EHH 3</4?G1N'J/SI:* $W#U'YT;AZC\Z6B@!-P]1^=&X>H_.EHH
M 3</4?G1N'J/SI:* $W#U'YT;AZC\Z6B@!-P]1^=&X>H_.EHH 3</4?G1N'J
M/SI:* $W#U'YT;AZC\Z6B@!-P]1^=&X>H_.EHH 3</4?G1N'J/SI:* $W#U'
MYT;AZC\Z6B@!-P]1^=&X>H_.EHH 3</4?G1N'J/SI:* $W#U'YT;AZC\Z6B@
M!-P]1^=&X>H_.EHH 3</4?G1N'J/SI:* $W#U'YT;AZC\Z6B@!-P]1^=&X>H
M_.EHH 3</4?G1N'J/SI:* $W#U'YT;AZC\Z6B@!-P]1^=&X>H_.EHH 3</4?
MG1N'J/SI:* $W#U'YT;AZC\Z6B@!-P]1^=&X>H_.EHH 3</4?G1N'J/SI:*
M$W#U'YT;AZC\Z6B@!-P]1^=&X>H_.EHH 3</4?G1N'J/SI:* $W#U'YT;AZC
M\Z6B@!-P]1^=&X>H_.EHH 3</4?G1N'J/SI:* $W#U'YT;AZC\Z6B@!-P]1^
@=&X>H_.EHH 3</4?G1N'J/SI:* $'?Z_T%%+10!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>fgen-20210811.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-08-11T05:11:33.8867468+00:00 -->
<!-- Version            : 5.0.1.648 -->
<!-- Package ID         : b3b6859626854044907f9bbd1850d6f6 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:fgen="http://www.fibrogen.com/20210811" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.fibrogen.com/20210811" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" namespace="http://xbrl.sec.gov/country/2021" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd" namespace="http://xbrl.sec.gov/currency/2021" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" namespace="http://xbrl.sec.gov/dei/2021" />
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd" namespace="http://xbrl.sec.gov/exch/2021" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/negated" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/net" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" namespace="http://xbrl.sec.gov/naics/2021" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd" namespace="http://xbrl.sec.gov/sic/2021" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" namespace="http://fasb.org/srt/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd" namespace="http://fasb.org/srt-roles/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" namespace="http://fasb.org/srt-types/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" namespace="http://xbrl.sec.gov/stpr/2021" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" namespace="http://fasb.org/us-gaap/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd" namespace="http://fasb.org/us-roles/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" namespace="http://fasb.org/us-types/2021-01-31" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType id="TemplateLink" roleURI="http://www.fibrogen.com/20210811/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>00000 - Document - Template Link</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="fgen-20210811_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="fgen-20210811_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.fibrogen.com/20210811/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>fgen-20210811_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-08-11T05:11:33.8867468+00:00 -->
<!-- Version            : 5.0.1.648 -->
<!-- Package ID         : b3b6859626854044907f9bbd1850d6f6 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/axisDefault" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#axisDefault" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of each class</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Name of each exchange on which registered</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>fgen-20210811_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-08-11T05:11:33.8867468+00:00 -->
<!-- Version            : 5.0.1.648 -->
<!-- Package ID         : b3b6859626854044907f9bbd1850d6f6 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.fibrogen.com/20210811/role/TemplateLink" xlink:href="fgen-20210811.xsd#TemplateLink" xlink:type="simple" />
  <link:roleRef roleURI="http://www.fibrogen.com/20210811/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="fgen-20210811.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.fibrogen.com/20210811/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>fgen-8k_20210811_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="fgen-20210811.xsd" xlink:type="simple"/>
    <context id="C_0000921299_20210811_20210811">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000921299</identifier>
        </entity>
        <period>
            <startDate>2021-08-11</startDate>
            <endDate>2021-08-11</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="C_0000921299_20210811_20210811" id="F_000001">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="C_0000921299_20210811_20210811" id="F_000004">0000921299</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="C_0000921299_20210811_20210811" id="F_000000">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="C_0000921299_20210811_20210811" id="F_000002">2021-08-11</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="C_0000921299_20210811_20210811" id="F_000003">FibroGen, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="C_0000921299_20210811_20210811" id="F_000007">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="C_0000921299_20210811_20210811" id="F_000006">001-36740</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="C_0000921299_20210811_20210811" id="F_000008">77-0357827</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="C_0000921299_20210811_20210811" id="F_000009">409 Illinois Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="C_0000921299_20210811_20210811" id="F_000010">San Francisco</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="C_0000921299_20210811_20210811" id="F_000011">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="C_0000921299_20210811_20210811" id="F_000012">94158</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="C_0000921299_20210811_20210811" id="F_000013">415</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="C_0000921299_20210811_20210811" id="F_000014">978-1200</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="C_0000921299_20210811_20210811" id="F_000015">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="C_0000921299_20210811_20210811" id="F_000016">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="C_0000921299_20210811_20210811" id="F_000017">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="C_0000921299_20210811_20210811" id="F_000018">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="C_0000921299_20210811_20210811" id="F_000019">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="C_0000921299_20210811_20210811" id="F_000020">FGEN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="C_0000921299_20210811_20210811" id="F_000021">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="C_0000921299_20210811_20210811" id="F_000005">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140392140450984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Aug. 11, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 11,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">FibroGen, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000921299<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36740<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">77-0357827<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">409 Illinois Street<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Francisco<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">978-1200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of each class</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">FGEN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Name of each exchange on which registered</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ U$,+4QPX9>H_ 0  / (
M  \   !X;"]W;W)K8F]O:RYX;6R-4<MNPD ,_)75?D 34(M41+B4/I"J%I6*
M^Y)UB,4^(J\#+5]?)U%4I%YZ\GILC6=F%^=(QWV,1_7E74B%KIF;>9:EL@9O
MTDUL(,BDBN0-2TN'+#4$QJ8:@+W+IGD^R[S!H)>+D6M#V743&4K&& 3L@!W"
M.?W.NU:=,.$>'?)WH?NW ZT\!O1X 5OH7*M4Q_-+)+S$P,9M2XK.%7HR#'9
MC.4?>-N)_#3[U"-L]A]&A!1ZE@MAA92XW^CYC6@\@2P/7<OQ"1T#K0S#,\6V
MP7#H:,1%=F6CSV&L0XAS^D^,L:JPA%4L6P^!AQP)7"<PI!J;I%4P'@H]KB@3
MK'H,+"&I=1BH9+=S*J?7=G#-(O<J0YJC#&AM!^&C6@L5!K!O<B )+LF5&U)=
MZ7FFMW>3>TFH=>Y!L/?P&HT=S8\?M_P!4$L#!!0    ( -1#"U,D'INBK0
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M;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ U$,+4XXE6_CN    *P(  !$
M             ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @
MU$,+4YE<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H
M96UE,2YX;6Q02P$"% ,4    " #40PM31F,_>S@$  !-$   &
M    @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @
MU$,+4Y^@&_"Q @  X@P   T              ( !>PP  'AL+W-T>6QE<RYX
M;6Q02P$"% ,4    " #40PM3EXJ[',     3 @  "P              @ %7
M#P  7W)E;',O+G)E;'-02P$"% ,4    " #40PM3'#AEZC\!   \ @  #P
M            @ % $   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ U$,+
M4R0>FZ*M    ^ $  !H              ( !K!$  'AL+U]R96QS+W=O<FMB
M;V]K+GAM;"YR96QS4$L! A0#%     @ U$,+4V60>9(9 0  SP,  !,
M         ( !D1(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^
) @  VQ,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="fgen-8k_20210811.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fibrogen.com/20210811/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="fgen-8k_20210811.htm">fgen-8k_20210811.htm</File>
    <File>fgen-20210811.xsd</File>
    <File>fgen-20210811_lab.xml</File>
    <File>fgen-20210811_pre.xml</File>
    <File>fgen-ex991_6.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "fgen-8k_20210811.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "fgen-8k_20210811.htm"
     ]
    },
    "labelLink": {
     "local": [
      "fgen-20210811_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "fgen-20210811_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "fgen-20210811.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "fgen",
   "nsuri": "http://www.fibrogen.com/20210811",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "fgen-8k_20210811.htm",
      "contextRef": "C_0000921299_20210811_20210811",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.fibrogen.com/20210811/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "fgen-8k_20210811.htm",
      "contextRef": "C_0000921299_20210811_20210811",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.fibrogen.com/20210811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.fibrogen.com/20210811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.fibrogen.com/20210811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.fibrogen.com/20210811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address Address Line1",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.fibrogen.com/20210811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.fibrogen.com/20210811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.fibrogen.com/20210811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.fibrogen.com/20210811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.fibrogen.com/20210811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.fibrogen.com/20210811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.fibrogen.com/20210811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.fibrogen.com/20210811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.fibrogen.com/20210811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.fibrogen.com/20210811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.fibrogen.com/20210811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.fibrogen.com/20210811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.fibrogen.com/20210811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security12b Title",
        "terseLabel": "Title of each class"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.fibrogen.com/20210811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Name of each exchange on which registered"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.fibrogen.com/20210811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.fibrogen.com/20210811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.fibrogen.com/20210811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.fibrogen.com/20210811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001564590-21-043233-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001564590-21-043233-xbrl.zip
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M/VY3"AF4B8E$;ZXKA#_M6B'F#5TVWBN[5?.78#1*&=ZH#C0<!*RNX!6 R)>
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M?OHM"5H-(0M!K@[4]/5+V<&)-SS7AZ?LI7M8:XN5>DW.E_(KX_H_4$L#!!0
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M)D@=(S) ]S9M)!]($UJV3.RRBA56SUI;2%U'3$R)RR"0M8ODQRVFR"LW';0
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M,#(Q,#@Q,2YX<V102P$"% ,4    " #40PM3I)CYYB('   .20  %0
M        @ 'F!   9F=E;BTR,#(Q,#@Q,5]L86(N>&UL4$L! A0#%     @
MU$,+4Y*35X#W!   4BL  !4              ( !.PP  &9G96XM,C R,3 X
M,3%?<')E+GAM;%!+ 0(4 Q0    ( -1#"U.C;F#@6!$  %V3   4
M      "  641  !F9V5N+3AK7S(P,C$P.#$Q+FAT;5!+ 0(4 Q0    ( -1#
M"U-M*/G;FPX  &]!   0              "  >\B  !F9V5N+65X.3DQ7S8N
9:'1M4$L%!@     %  4 10$  +@Q      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
